Xenon Pharmaceuticals Inc (XENE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Sales | 0 | 16 | 264 | 15 | 16 |
| Gross Profit | N/A | 16 | 264 | 15 | 16 |
| Operating Expenses | 7,806 | 8,067 | 8,908 | 7,908 | 8,003 |
| Operating Income | -7,806 | -8,051 | -8,644 | -7,893 | -7,987 |
| Interest Expense | 159 | 0 | 0 | 0 | 0 |
| Other Income | 4,222 | -14 | 902 | 513 | 470 |
| Pre-tax Income | -3,743 | -8,065 | -7,742 | -7,380 | -7,517 |
| Income Tax | 12 | N/A | N/A | N/A | N/A |
| Net Income Continuous | -3,755 | -8,065 | -7,742 | -7,380 | -7,517 |
| Net Income | $-3,755 | $-8,065 | $-7,742 | $-7,380 | $-7,517 |
| EPS Basic Total Ops | -0.21 | -0.45 | -0.43 | -0.41 | -0.42 |
| EPS Basic Continuous Ops | -0.21 | -0.45 | -0.43 | -0.41 | -0.42 |
| EPS Diluted Total Ops | -0.21 | -0.45 | -0.43 | -0.41 | -0.43 |
| EPS Diluted Continuous Ops | -0.21 | -0.45 | -0.43 | -0.41 | -0.42 |
| EBITDA(a) | $-7,584 | $-7,893 | $-8,476 | $-7,724 | $-7,822 |